This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of anti-cytokine targeted therapy for patients with ANCA-associated vasculitis in terms of the following primary outcomes: mortality, disease activity (remission, durable remission, disease relapse) and adverse events such as withdrawals due to adverse events, total adverse events and serious adverse events.
CITATION STYLE
Bala, M. M., Malecka-Massalska, T. J., Koperny, M., Zajac, J. F., & Szczeklik, W. (2010). Anti-cytokine targeted therapies for ANCA-associated vasculitis. Cochrane Database of Systematic Reviews, 2017(3). https://doi.org/10.1002/14651858.CD008333
Mendeley helps you to discover research relevant for your work.